Published in Brain Res on October 08, 2010
Pathological α-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science (2012) 6.66
Gender, sex steroid hormones, and Alzheimer's disease. Horm Behav (2012) 1.14
Sex hormones, aging, and Alzheimer's disease. Front Biosci (Elite Ed) (2012) 1.06
Estrogens, Neuroinflammation, and Neurodegeneration. Endocr Rev (2016) 0.87
Sex-specific effects of high fat diet on indices of metabolic syndrome in 3xTg-AD mice: implications for Alzheimer's disease. PLoS One (2013) 0.84
The APOE4 allele shows opposite sex bias in microbleeds and Alzheimer's disease of humans and mice. Neurobiol Aging (2015) 0.83
Brain endogenous estrogen levels determine responses to estrogen replacement therapy via regulation of BACE1 and NEP in female Alzheimer's transgenic mice. Mol Neurobiol (2012) 0.83
3xTg-AD mice exhibit an activated central stress axis during early-stage pathology. J Alzheimers Dis (2013) 0.82
Differential control of sex differences in estrogen receptor α in the bed nucleus of the stria terminalis and anteroventral periventricular nucleus. Endocrinology (2013) 0.82
The relationship between iron dyshomeostasis and amyloidogenesis in Alzheimer's disease: Two sides of the same coin. Neurobiol Dis (2015) 0.81
Apolipoprotein E and Sex Bias in Cerebrovascular Aging of Men and Mice. Trends Neurosci (2016) 0.81
Loss of deep cerebellar nuclei neurons in the 3xTg-AD mice and protection by an anti-amyloid β antibody fragment. MAbs (2013) 0.79
Sex hormone-related neurosteroids differentially rescue bioenergetic deficits induced by amyloid-β or hyperphosphorylated tau protein. Cell Mol Life Sci (2015) 0.78
Evaluation of the effects of testosterone and luteinizing hormone on regulation of β-amyloid in male 3xTg-AD mice. Brain Res (2012) 0.78
Broad-based nutritional supplementation in 3xTg mice corrects mitochondrial function and indicates sex-specificity in response to Alzheimer's disease intervention. J Alzheimers Dis (2012) 0.77
Sex and gonadal hormones in mouse models of Alzheimer's disease: what is relevant to the human condition? Biol Sex Differ (2012) 0.77
BBB-Permeable, Neuroprotective, and Neurotrophic Polysaccharide, Midi-GAGR. PLoS One (2016) 0.77
Age-dependent inverse correlations in CSF and plasma amyloid-β(1-42) concentrations prior to amyloid plaque deposition in the brain of 3xTg-AD mice. Sci Rep (2016) 0.76
Obesity and sex interact in the regulation of Alzheimer's disease. Neurosci Biobehav Rev (2015) 0.76
Sex and the development of Alzheimer's disease. J Neurosci Res (2017) 0.76
Interactions between inflammation, sex steroids, and Alzheimer's disease risk factors. Front Neuroendocrinol (2016) 0.75
Differential contributions of ApoE4 and female sex to BACE1 activity and expression mediate Aβ deposition and learning and memory in mouse models of Alzheimer's disease. Front Aging Neurosci (2015) 0.75
Tau accumulation in the retina promotes early neuronal dysfunction and precedes brain pathology in a mouse model of Alzheimer's disease. Mol Neurodegener (2017) 0.75
Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science (1996) 19.72
Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron (2003) 14.03
Unbiased stereological estimation of the total number of neurons in thesubdivisions of the rat hippocampus using the optical fractionator. Anat Rec (1991) 11.44
Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet (1996) 7.10
Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study. JAMA (2002) 6.72
The prevalence of dementia: a quantitative integration of the literature. Acta Psychiatr Scand (1987) 6.19
Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes. Nat Med (1998) 5.78
Why sex matters for neuroscience. Nat Rev Neurosci (2006) 4.75
Normal sexual dimorphism of the adult human brain assessed by in vivo magnetic resonance imaging. Cereb Cortex (2001) 4.03
Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study. JAMA (2004) 3.85
The incidence of dementia: a meta-analysis. Neurology (1998) 3.06
Evolving knowledge of sex differences in brain structure, function, and chemistry. Biol Psychiatry (2007) 3.02
Sexual differentiation of the vertebrate nervous system. Nat Neurosci (2004) 2.95
2nd to 4th digit ratios, fetal testosterone and estradiol. Early Hum Dev (2004) 2.95
Prevalence of dementia and probable senile dementia of the Alzheimer type in the Framingham Study. Neurology (1992) 2.64
Sex differences in the neural basis of emotional memories. Proc Natl Acad Sci U S A (2002) 2.56
Chronic stress impairs rat spatial memory on the Y maze, and this effect is blocked by tianeptine pretreatment. Behav Neurosci (1996) 2.46
Age-related testosterone depletion and the development of Alzheimer disease. JAMA (2004) 2.45
A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore Longitudinal Study of Aging. Neurology (1997) 2.30
Sexual differentiation in litter-bearing mammals: influence of sex of adjacent fetuses in utero. J Anim Sci (1989) 2.16
Sex-related difference in amygdala activity during emotionally influenced memory storage. Neurobiol Learn Mem (2001) 2.15
Gender differences in the incidence of AD and vascular dementia: The EURODEM Studies. EURODEM Incidence Research Group. Neurology (1999) 2.13
Sex differences in the clinical manifestations of Alzheimer disease pathology. Arch Gen Psychiatry (2005) 2.08
Progesterone and estrogen regulate Alzheimer-like neuropathology in female 3xTg-AD mice. J Neurosci (2007) 2.00
Behavioral characterization of the Tg2576 transgenic model of Alzheimer's disease through 19 months. Physiol Behav (2002) 1.99
Free testosterone and risk for Alzheimer disease in older men. Neurology (2004) 1.88
Augmented senile plaque load in aged female beta-amyloid precursor protein-transgenic mice. Am J Pathol (2001) 1.87
Neuroprotective effects of female gonadal steroids in reproductively senescent female rats. Stroke (2000) 1.83
Plasma testosterone and progesterone titers of pregnant rats, their male and female fetuses, and neonatal offspring. Endocrinology (1980) 1.82
Incidence of dementia: does gender make a difference? Neurobiol Aging (2001) 1.81
Protective actions of sex steroid hormones in Alzheimer's disease. Front Neuroendocrinol (2009) 1.71
Contribution by synaptic zinc to the gender-disparate plaque formation in human Swedish mutant APP transgenic mice. Proc Natl Acad Sci U S A (2002) 1.68
Estrogen replacement therapy and risk of Alzheimer disease. Arch Intern Med (1996) 1.57
Longitudinal studies of estrous cyclicity in aging C57BL/6J mice: II. Cessation of cyclicity and the duration of persistent vaginal cornification. Biol Reprod (1984) 1.56
Relationship between testosterone, sex hormone binding globulin and plasma amyloid beta peptide 40 in older men with subjective memory loss or dementia. J Alzheimers Dis (2003) 1.52
Females exhibit more extensive amyloid, but not tau, pathology in an Alzheimer transgenic model. Brain Res (2008) 1.51
Estrogen replacement therapy in older women. Comparisons between Alzheimer's disease cases and nondemented control subjects. Arch Neurol (1994) 1.50
Gender differences in the amount and deposition of amyloidbeta in APPswe and PS1 double transgenic mice. Neurobiol Dis (2003) 1.48
Androgens protect against apolipoprotein E4-induced cognitive deficits. J Neurosci (2002) 1.44
Progressive and gender-dependent cognitive impairment in the APP(SW) transgenic mouse model for Alzheimer's disease. Behav Brain Res (1999) 1.34
Gender differences in the functional organization of the brain for working memory. Neuroreport (2000) 1.33
A previously uncharacterized role for estrogen receptor beta: defeminization of male brain and behavior. Proc Natl Acad Sci U S A (2005) 1.32
Sex differences in growth of rats, and their modification by a single injection of testosterone propionate shortly after birth. J Endocrinol (1963) 1.30
Estrogen modulates neuronal Bcl-xL expression and beta-amyloid-induced apoptosis: relevance to Alzheimer's disease. J Neurochem (1999) 1.30
The biphasic relationship between regional brain senile plaque and neurofibrillary tangle distributions: modification by age, sex, and APOE polymorphism. Ann N Y Acad Sci (2004) 1.29
Epidemiology of clinically diagnosed Alzheimer's disease. Ann Neurol (1986) 1.24
Selective estrogen receptor modulators differentially regulate Alzheimer-like changes in female 3xTg-AD mice. Endocrinology (2008) 1.22
Androgens regulate the development of neuropathology in a triple transgenic mouse model of Alzheimer's disease. J Neurosci (2006) 1.21
Developmental programming and endocrine disruptor effects on reproductive neuroendocrine systems. Front Neuroendocrinol (2008) 1.21
Prenatal gonadal steroids affect adult spatial behavior, CA1 and CA3 pyramidal cell morphology in rats. Horm Behav (1998) 1.20
Neurotrophin expression in the reproductively senescent forebrain is refractory to estrogen stimulation. Neurobiol Aging (2001) 1.19
Continuous and cyclic progesterone differentially interact with estradiol in the regulation of Alzheimer-like pathology in female 3xTransgenic-Alzheimer's disease mice. Endocrinology (2010) 1.18
Altered profiles of estradiol and progesterone associated with prolonged estrous cycles and persistent vaginal cornification in aging C57BL/6J mice. Biol Reprod (1981) 1.16
Effects of neonatal gonadal steroids on adult CA3 pyramidal neuron dendritic morphology and spatial memory in rats. J Neurobiol (2003) 1.16
Estrogens and neuroprotection. Trends Endocrinol Metab (2002) 1.15
Brain levels of sex steroid hormones in men and women during normal aging and in Alzheimer's disease. Neurobiol Aging (2009) 1.14
Sexually dimorphic synaptic organization of the medial amygdala. J Neurosci (2005) 1.14
Serum total testosterone is lower in men with Alzheimer's disease. Neuro Endocrinol Lett (2001) 1.13
Pathogenic mechanisms of Alzheimer's disease analyzed in the APP23 transgenic mouse model. Ann N Y Acad Sci (2000) 1.12
Ovariectomy and 17beta-estradiol modulate the levels of Alzheimer's amyloid beta peptides in brain. Exp Gerontol (2000) 1.11
Role for estradiol in female-typical brain and behavioral sexual differentiation. Front Neuroendocrinol (2007) 1.11
Gender and the injured brain. Anesth Analg (2008) 1.10
Correlation between testosterone, gonadotropins and prolactin and severity of negative symptoms in male patients with chronic schizophrenia. Schizophr Res (2006) 1.09
Modulation of A(beta) peptides by estrogen in mouse models. J Neurochem (2002) 1.09
Differential effects of estrogen in the injured forebrain of young adult and reproductive senescent animals. Neurobiol Aging (2003) 1.08
A sex difference on a novel spatial working memory task in humans. Brain Cogn (2001) 1.08
Sex differences in the responses of the human amygdala. Neuroscientist (2005) 1.05
Sexual dimorphism in the mammalian limbic system. Prog Neurobiol (1995) 1.04
How it's made: organisational effects of hormones on the developing brain. J Neuroendocrinol (2010) 1.02
Intrauterine position effects on anogenital distance and digit ratio in male and female mice. Arch Sex Behav (2008) 1.02
Reduction of cholesterol synthesis in the mouse brain does not affect amyloid formation in Alzheimer's disease, but does extend lifespan. Proc Natl Acad Sci U S A (2009) 1.02
17Alpha-estradiol and 17beta-estradiol treatments are effective in lowering cerebral amyloid-beta levels in AbetaPPSWE transgenic mice. J Alzheimers Dis (2002) 1.02
Brain sexual differentiation and gonadotropins secretion in the rat. Cell Mol Neurobiol (1997) 0.99
Mechanisms mediating oestradiol modulation of the developing brain. J Neuroendocrinol (2008) 0.99
Genetic targeting aromatase in male amyloid precursor protein transgenic mice down-regulates beta-secretase (BACE1) and prevents Alzheimer-like pathology and cognitive impairment. J Neurosci (2010) 0.98
SDN-POA volume, sexual behavior, and partner preference of male rats affected by perinatal treatment with ATD. Physiol Behav (1994) 0.95
Müllerian inhibiting substance contributes to sex-linked biases in the brain and behavior. Proc Natl Acad Sci U S A (2009) 0.93
Plasma concentrations of estradiol in women suffering from schizophrenia treated with conventional versus atypical antipsychotics. Schizophr Res (2005) 0.93
Postnatal masculinization alters the HPA axis phenotype in the adult female rat. J Physiol (2004) 0.93
Structural and functional sex differences in the human hypothalamus. Horm Behav (2001) 0.92
Prenatal and early postnatal sex differences in plasma and gonadal testosterone and plasma luteinizing hormone in female and male rats. J Endocrinol (1980) 0.92
Neonatal androgenization of hypogonadal (hpg) male mice does not abolish estradiol-induced FSH production and spermatogenesis. Reprod Biol Endocrinol (2005) 0.91
The gonadotropin connection in Alzheimer's disease. Endocrine (2005) 0.91
Neonatal sex hormones have 'organizational' effects on the hypothalamic-pituitary-adrenal axis of male rats. Brain Res Dev Brain Res (1998) 0.88
Time-specific androgen blockade with flutamide inhibits testicular descent in the rat. Endocrinology (1991) 0.87
Reversal of normal cerebral sexual dimorphism in schizophrenia: evidence and speculations. Med Hypotheses (2007) 0.87
Digit length pattern in schizophrenia suggests disturbed prenatal hemispheric lateralization. Prog Neuropsychopharmacol Biol Psychiatry (2004) 0.84
Comparison of estrogen and androgen levels after oral estrogen replacement therapy. J Reprod Med (2001) 0.84
Augmented axonal defects and synaptic degenerative changes in female GRK5 deficient mice. Brain Res Bull (2008) 0.83
Evidence for the role of gonadotropin hormones in the development of Alzheimer disease. Cell Mol Life Sci (2005) 0.83
Metabolism of steroids in the brain: a new insight into the role of 5alpha-reductase and aromatase in brain differentiation and functions. J Steroid Biochem Mol Biol (1996) 0.82
Persistent effects of prenatal, neonatal, or adult treatment with flutamide on the hypothalamic-pituitary-adrenal stress response of adult male rats. Horm Behav (1999) 0.82
Acquisition of conditioned taste aversion is impaired in the amyloid precursor protein/presenilin 1 mouse model of Alzheimer's disease. Neuroscience (2008) 0.82
Gender dependent APP processing in a transgenic mouse model of Alzheimer's disease. J Neural Transm (Vienna) (2006) 0.82
The role of gonadotropins in Alzheimer's disease: potential neurodegenerative mechanisms. Endocrine (2006) 0.81
Effect of prenatal androgen receptor antagonist or aromatase inhibitor on sexual behavior, partner preference and neuronal Fos responses to estrous female odors in the rat accessory olfactory system. Physiol Behav (2002) 0.81
Perinatal androgenization prevents age-related neuron loss in the sexually dimorphic nucleus of the preoptic area in female rats. Dev Neurosci (2004) 0.80
Neonatal androgen and estrogen treatments masculinize the size of motoneurons in the rat spinal nucleus of the bulbocavernosus. Cell Mol Neurobiol (1997) 0.80
Adiposity and sex hormones in postmenopausal breast cancer survivors. J Clin Oncol (2003) 2.65
Age-related testosterone depletion and the development of Alzheimer disease. JAMA (2004) 2.45
Serum 25-hydroxyvitamin D concentrations and risk for hip fractures. Ann Intern Med (2008) 2.44
Accelerated endometrial maturation in the luteal phase of cycles utilizing controlled ovarian hyperstimulation: impact of gonadotropin-releasing hormone agonists versus antagonists. Fertil Steril (2004) 2.33
Body size and serum levels of insulin and leptin in relation to the risk of benign prostatic hyperplasia. J Urol (2002) 2.27
Retracted Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results from the National Institutes of Health--National Heart, Lung, and Blood Institute sponsored Women's Ischemia Syndrome Evaluation. J Clin Endocrinol Metab (2008) 2.21
Relation of BMI and physical activity to sex hormones in postmenopausal women. Obesity (Silver Spring) (2006) 2.17
Progesterone receptors: form and function in brain. Front Neuroendocrinol (2008) 2.15
Effect of exercise on serum estrogens in postmenopausal women: a 12-month randomized clinical trial. Cancer Res (2004) 2.14
Alberta physical activity and breast cancer prevention trial: sex hormone changes in a year-long exercise intervention among postmenopausal women. J Clin Oncol (2010) 2.00
Progesterone and estrogen regulate Alzheimer-like neuropathology in female 3xTg-AD mice. J Neurosci (2007) 2.00
Pharmacokinetics of a combined oral contraceptive in obese and normal-weight women. Contraception (2010) 1.96
Beta-amyloid oligomers induce phosphorylation of tau and inactivation of insulin receptor substrate via c-Jun N-terminal kinase signaling: suppression by omega-3 fatty acids and curcumin. J Neurosci (2009) 1.88
Sleep duration, spot urinary 6-sulfatoxymelatonin levels and risk of breast cancer among Chinese women in Singapore. Int J Cancer (2012) 1.82
Comparison of methods to measure low serum estradiol levels in postmenopausal women. J Clin Endocrinol Metab (2006) 1.76
Protective actions of sex steroid hormones in Alzheimer's disease. Front Neuroendocrinol (2009) 1.71
Effectiveness of levonorgestrel emergency contraception given before or after ovulation--a pilot study. Contraception (2006) 1.68
Ovarian androgen production in postmenopausal women. J Clin Endocrinol Metab (2007) 1.66
Reduced-calorie dietary weight loss, exercise, and sex hormones in postmenopausal women: randomized controlled trial. J Clin Oncol (2012) 1.66
Sleep duration, melatonin and breast cancer among Chinese women in Singapore. Carcinogenesis (2008) 1.63
Insulin resistance and prostate cancer risk. J Natl Cancer Inst (2003) 1.61
Circulating adipokine levels and endometrial cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol Biomarkers Prev (2013) 1.58
Antimüllerian hormone as a predictor of natural fecundability in women aged 30-42 years. Obstet Gynecol (2011) 1.56
Racial/ethnic differences in postmenopausal endogenous hormones: the multiethnic cohort study. Cancer Epidemiol Biomarkers Prev (2006) 1.56
Reproducibility of serum sex steroid assays in men by RIA and mass spectrometry. Cancer Epidemiol Biomarkers Prev (2007) 1.53
Impact of obesity on oral contraceptive pharmacokinetics and hypothalamic-pituitary-ovarian activity. Contraception (2009) 1.52
Correlation of serum androgens with anthropometric and metabolic indices in healthy, nonobese postmenopausal women. J Clin Endocrinol Metab (2010) 1.46
Clinical effects of selective estrogen receptor modulators on vulvar and vaginal atrophy. Menopause (2014) 1.46
Locus-wide chromatin remodeling and enhanced androgen receptor-mediated transcription in recurrent prostate tumor cells. Mol Cell Biol (2006) 1.46
Effect of bilateral oophorectomy on adrenocortical function in women with polycystic ovary syndrome. Fertil Steril (2012) 1.45
Selective reduction of AKR1C2 in prostate cancer and its role in DHT metabolism. Prostate (2003) 1.40
Reliability of extraction/chromatography RIAs. Clin Chem (2004) 1.40
Relationship between serum levels of sex hormones and progression of subclinical atherosclerosis in postmenopausal women. J Clin Endocrinol Metab (2007) 1.38
Comparison of fallers and nonfallers at an inpatient rehabilitation facility: a retrospective review. Rehabil Nurs (2012) 1.38
Association of CYP17, CYP19, CYP1B1, and COMT polymorphisms with serum and urinary sex hormone concentrations in postmenopausal women. Cancer Epidemiol Biomarkers Prev (2004) 1.35
Oral contraceptives and individual variability of circulating levels of ethinyl estradiol and progestins. Contraception (2008) 1.34
Serum steroid and sex hormone-binding globulin concentrations and the risk of incident benign prostatic hyperplasia: results from the prostate cancer prevention trial. Am J Epidemiol (2008) 1.34
Effect of exercise on serum androgens in postmenopausal women: a 12-month randomized clinical trial. Cancer Epidemiol Biomarkers Prev (2004) 1.30
Reproductive steroid hormones and recurrence-free survival in women with a history of breast cancer. Cancer Epidemiol Biomarkers Prev (2008) 1.29
Androgen cell signaling pathways involved in neuroprotective actions. Horm Behav (2007) 1.28
Peroxisome proliferator-activated receptor (PPAR)α and -γ regulate IFNγ and IL-17A production by human T cells in a sex-specific way. Proc Natl Acad Sci U S A (2012) 1.26
Hormones and prostate cancer: current perspectives and future directions. Prostate (2002) 1.26
Associations among circulating sex hormones, insulin-like growth factor, lipids, and mammographic density in postmenopausal women. Cancer Epidemiol Biomarkers Prev (2005) 1.26
Effects of a 2-year randomized soy intervention on sex hormone levels in premenopausal women. Cancer Epidemiol Biomarkers Prev (2004) 1.24
Ovarian suppression in normal-weight and obese women during oral contraceptive use: a randomized controlled trial. Obstet Gynecol (2010) 1.23
Selective estrogen receptor modulators differentially regulate Alzheimer-like changes in female 3xTg-AD mice. Endocrinology (2008) 1.22
Androgens regulate the development of neuropathology in a triple transgenic mouse model of Alzheimer's disease. J Neurosci (2006) 1.21
Androgens activate mitogen-activated protein kinase signaling: role in neuroprotection. J Neurochem (2005) 1.20
Beta-amyloid-induced neuronal apoptosis involves c-Jun N-terminal kinase-dependent downregulation of Bcl-w. J Neurosci (2005) 1.20
Continuous and cyclic progesterone differentially interact with estradiol in the regulation of Alzheimer-like pathology in female 3xTransgenic-Alzheimer's disease mice. Endocrinology (2010) 1.18
Progestins inhibit the neuroprotective effects of estrogen in rat hippocampus. Brain Res (2006) 1.17
Antimullerian hormone and obesity: insights in oral contraceptive users. Contraception (2009) 1.16
Brain levels of sex steroid hormones in men and women during normal aging and in Alzheimer's disease. Neurobiol Aging (2009) 1.14
Androgen and prostate cancer: is the hypothesis dead? Cancer Epidemiol Biomarkers Prev (2008) 1.14
Gender, sex steroid hormones, and Alzheimer's disease. Horm Behav (2012) 1.14
Predictors of noncompliance in an oral contraceptive clinical trial. Contraception (2011) 1.13
Night shift work and hormone levels in women. Cancer Epidemiol Biomarkers Prev (2012) 1.12
Reduction of SorLA/LR11, a sorting protein limiting beta-amyloid production, in Alzheimer disease cerebrospinal fluid. Arch Neurol (2009) 1.12
Tea and circulating estrogen levels in postmenopausal Chinese women in Singapore. Carcinogenesis (2005) 1.12
Phase I study of STX 64 (667 Coumate) in breast cancer patients: the first study of a steroid sulfatase inhibitor. Clin Cancer Res (2006) 1.10
Mammographic densities and circulating hormones: a cross-sectional study in premenopausal women. Breast (2005) 1.10
Dietary patterns and breast cancer risk in Asian American women. Am J Clin Nutr (2009) 1.10
No effect of exercise on insulin-like growth factor 1 and insulin-like growth factor binding protein 3 in postmenopausal women: a 12-month randomized clinical trial. Cancer Epidemiol Biomarkers Prev (2005) 1.09
Metabolism and pharmacokinetics of contraceptive steroids in obese women: a review. Contraception (2010) 1.08
Genetic variants of DNA repair genes and prostate cancer: a population-based study. Cancer Epidemiol Biomarkers Prev (2005) 1.06
Estrogen regulates Bcl-w and Bim expression: role in protection against beta-amyloid peptide-induced neuronal death. J Neurosci (2007) 1.06
Sex hormones, aging, and Alzheimer's disease. Front Biosci (Elite Ed) (2012) 1.06
A prospective evaluation of C-reactive protein levels and colorectal adenoma development. Cancer Epidemiol Biomarkers Prev (2011) 1.06
Interaction of St. John's Wort with oral contraceptives: effects on the pharmacokinetics of norethindrone and ethinyl estradiol, ovarian activity and breakthrough bleeding. Contraception (2005) 1.06
A controlled 2-mo dietary fat reduction and soy food supplementation study in postmenopausal women. Am J Clin Nutr (2005) 1.05
UDP-glucuronosyltransferase and sulfotransferase polymorphisms, sex hormone concentrations, and tumor receptor status in breast cancer patients. Breast Cancer Res (2004) 1.05
Selective loss of AKR1C1 and AKR1C2 in breast cancer and their potential effect on progesterone signaling. Cancer Res (2004) 1.05
Prospective case-control study of serum mullerian inhibiting substance and breast cancer risk. J Natl Cancer Inst (2009) 1.04
Associations between reproductive and menstrual factors and postmenopausal sex hormone concentrations. Cancer Epidemiol Biomarkers Prev (2004) 1.04
Plasma sex hormone concentrations and breast cancer risk in an ethnically diverse population of postmenopausal women: the Multiethnic Cohort Study. Endocr Relat Cancer (2010) 1.04
Prolonged monitoring of ethinyl estradiol and levonorgestrel levels confirms an altered pharmacokinetic profile in obese oral contraceptives users. Contraception (2012) 1.04
Acute effects of metformin therapy include improvement of insulin resistance and ovarian morphology. Fertil Steril (2007) 1.02
Clinical review: DHEA replacement for postmenopausal women. J Clin Endocrinol Metab (2011) 1.02
Ligand for translocator protein reverses pathology in a mouse model of Alzheimer's disease. J Neurosci (2013) 1.02
Estrogen activates protein kinase C in neurons: role in neuroprotection. J Neurochem (2003) 1.02
Effect of 2-month controlled green tea intervention on lipoprotein cholesterol, glucose, and hormone levels in healthy postmenopausal women. Cancer Prev Res (Phila) (2012) 1.02
Changes in the mouse estrus cycle in response to BRCA1 inactivation suggest a potential link between risk factors for familial and sporadic ovarian cancer. Cancer Res (2009) 1.01
Relation of demographic factors, menstrual history, reproduction and medication use to sex hormone levels in postmenopausal women. Breast Cancer Res Treat (2007) 1.01
Neuroprotective properties of selective estrogen receptor agonists in cultured neurons. Brain Res (2005) 1.01
Changes in insulin resistance indicators, IGFs, and adipokines in a year-long trial of aerobic exercise in postmenopausal women. Endocr Relat Cancer (2011) 1.01
Decreased endopelvic fascia elastin content in uterine prolapse. Acta Obstet Gynecol Scand (2008) 0.99
Flutamide and cyproterone acetate exert agonist effects: induction of androgen receptor-dependent neuroprotection. Endocrinology (2007) 0.99
Dietary fiber intake and endogenous serum hormone levels in naturally postmenopausal Mexican American women: the Multiethnic Cohort Study. Nutr Cancer (2007) 0.99
Serum estrogen levels and prostate cancer risk in the prostate cancer prevention trial: a nested case-control study. Cancer Causes Control (2011) 0.98
Methods and baseline cardiovascular data from the Early versus Late Intervention Trial with Estradiol testing the menopausal hormone timing hypothesis. Menopause (2015) 0.98